Muscarinic Receptor M3R Signaling Prevents Efficient Remyelination by Human and Mouse Oligodendrocyte Progenitor Cells
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Muscarinic receptor antagonists act as potent inducers of oligodendrocyte differentiation and accelerate remyelination. However, the use of muscarinic antagonists in the clinic is limited by poor understanding of the operant receptor subtype, and questions regarding possible species differences between rodents and humans. Based on high selective expression in human oligodendrocyte progenitor cells (OPCs), we hypothesized that M3R is the functionally relevant receptor. Lentiviral M3R knockdown in human primary CD140a/PDGFαR+ OPCs resulted in enhanced differentiation in vitro and substantially reduced the calcium response following muscarinic agonist treatment. Importantly, following transplantation in hypomyelinating shiverer/rag2 mice, M3R knockdown improved remyelination by human OPCs. Furthermore, conditional M3R ablation in adult NG2-expressing OPCs increased oligodendrocyte differentiation and led to improved spontaneous remyelination in mice. Together, we demonstrate that M3R receptor mediates muscarinic signaling in human OPCs that act to delay differentiation and remyelination, suggesting that M3 receptors are viable targets for human demyelinating disease. SIGNIFICANCE STATEMENT The identification of drug targets aimed at improving remyelination in patients with demyelination disease is a key step in development of effective regenerative therapies to treat diseases, such as multiple sclerosis. Muscarinic receptor antagonists have been identified as effective potentiators of remyelination, but the receptor subtypes that mediate these receptors are unclear. In this study, we show that genetic M3R ablation in both mouse and human cells results in improved remyelination and is mediated by acceleration of oligodendrocyte commitment from oligodendrocyte progenitor cells. Therefore, M3R represents an attractive target for induced remyelination in human disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875
Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
Trapp, B. D., & Nave, K.-A. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094313 · Cited by 1,724 · cited 2×
“Indeed, as remyelination acts to protect the demyelinated axons (Irvine and Blakemore, 2008), approaches that accelerate remyelination will yield additional functional benefits by acting to prevent the progressive neurodegeneration that is associated with chronic demyelination (Trapp and Nave, 2008).”
BackgroundDisruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination
Lappe-Siefke, C., Goebbels, S., Gravel, M., Nicksch, E., Lee, J., Braun, P. E., Griffiths, I. R., & Nave, K.-A. (2003) · Nature Genetics · doi:10.1038/ng1095 · Cited by 1,036 · cited 2×
“Likewise, conditional deletion of M1R was achieved using the CNP-cre mouse (Lappe-Siefke et al., 2003), which drives recombination primarily in immature oligodendrocytes after the formation of OPCs (Ye et al., 2009).”
MethodSmart, I. H. M. (2002) · Cerebral Cortex · doi:10.1093/cercor/12.1.37 · Cited by 687 · cited 1×
“Intriguingly, a direct comparison of M3R-positive and M3R-negative hOPCs identified G q-associated transcripts as the most significantly regulated gene set among pathways in the mSigDB (q 1.33 10 7; ST_GAQ_PATHWAY) (Subramanian et al., 2005).”
BackgroundInfluentialProliferation of oligodendrocyte precursor cells depends on electrical activity in axons
Barres, B. A., & Raff, M. C. (1993) · Nature · doi:10.1038/361258a0 · Cited by 673 · cited 2×
“Thus, neuronal activity, which drives OPC proliferation and differentiation in the developing brain (Barres and Raff, 1993; Gibson et al., 2014), may act in a neurotransmitter-specific manner to regulate diverse Ca 2 - dependent signals to it turn regulate OPC homeostasis.”
BackgroundControl of local protein synthesis and initial events in myelination by action potentials
Wake, H., Lee, P. R., & Fields, R. D. (2011) · Science · doi:10.1126/science.1206998 · Cited by 636 · cited 1×
“MBP ensheathment of host axons was assessed in the corpus callosum as previously described (Wang et al., 2014).”
MethodWang, S., Bates, J., Li, X., Schanz, S., Chandler-Militello, D., Levine, C., Maherali, N., Studer, L., Hochedlinger, K., Windrem, M., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.12.002 · Cited by 586 · cited 1×
“Similarly, while transplanted human OPCs (hOPCs) have the capacity to myelinate large areas of the hypomyelinated rodent brain, they do so very slowly over several months (Windrem et al., 2008; Wang et al., 2013).”
BackgroundWolswijk, G. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-02-00601.1998 · Cited by 562
HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the β-catenin–TCF interaction
Ye, F., Chen, Y., Hoang, T., Montgomery, R. L., Zhao, X.-H., Bu, H., Hu, T., Taketo, M. M., van Es, J. H., Clevers, H., et al. (2009) · Nature Neuroscience · doi:10.1038/nn.2333 · Cited by 559 · cited 1×
“Likewise, conditional deletion of M1R was achieved using the CNP-cre mouse (Lappe-Siefke et al., 2003), which drives recombination primarily in immature oligodendrocytes after the formation of OPCs (Ye et al., 2009).”
Method
Cited by
Stem cell derived oligodendrocytes to study myelin diseases
Chanoumidou, K., Mozafari, S., Baron‐Van Evercooren, A., & Kuhlmann, T. (2020) · Glia · doi:10.1002/glia.23733 · Cited by 62
Kumar Podder, A., Mohamed, M. A., Seidman, R. A., Tseropoulos, G., Polanco, J. J., Lei, P., Sim, F. J., & Andreadis, S. T. (2024) · Science Advances · doi:10.1126/sciadv.adk9918 · Cited by 22
Self-citationVersatile and automated workflow for the analysis of oligodendroglial calcium signals
Maas, D. A., Manot-Saillet, B., Bun, P., Habermacher, C., Poilbout, C., Rusconi, F., & Angulo, M. C. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05065-3 · Cited by 3
Metadata
- Authors
- Welliver, R. R., Polanco, J. J., Seidman, R. A., Sinha, A. K., O'Bara, M. A., Khaku, Z. M., Santiago González, D. A., Nishiyama, A., Wess, J., Feltri, M. L., Paez, P. M., & Sim, F. J.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2018-06-29
- Volume
- 38
- Issue
- 31
- Pages
- 6921-6932
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2811356603
- Cited by
- 46
- References
- 22
- FWCI
- 1.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Muscarinic Receptor M3R Signaling Prevents Efficient Remyelination by Human and Mouse Oligodendrocyte Progenitor Cells. https://app.cochat.ai/papers/10.1523/jneurosci.1862-17.2018
- The paper
- Welliver, R. R., Polanco, J. J., Seidman, R. A., Sinha, A. K., O'Bara, M. A., Khaku, Z. M., Santiago González, D. A., Nishiyama, A., Wess, J., Feltri, M. L., Paez, P. M., & Sim, F. J. (2018). Muscarinic Receptor M3R Signaling Prevents Efficient Remyelination by Human and Mouse Oligodendrocyte Progenitor Cells. The Journal of Neuroscience. https://doi.org/10.1523/jneurosci.1862-17.2018
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.